IshtiaqS,FogelmanI,HampsonG, 2015.Treatment of postmenopausal osteoporosis: beyond bisphosphonates,J Endocr Invest 38 13 -29
CairoliE,ZhukouskayaV,Eller-VainicherC,ChiodiniI., 2015.Perspectives on osteoporosis therapies,J Endocr Invest 38 303 -11
LeuchtP,HelmsJA, 2015.Wnt signaling: An emerging target for bone regeneration,J Am Acad Orthop Surg 23 67 -68
ZhaoR, 2012.Immune regulation of osteoclast function in postmenopausal osteoporosis: a critical interdisciplinary perspective,Int J Med Sci 9 825 -
GennariL,MerlottiD,NutiR, 2010.Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene,Clin Interv Aging 5 19 -29
LiX,OminskyMS,WarmingtonKS,MoronyS,GongJ,CaoJ, 2009.Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis,J Bone Miner Res 24 578 -88
BlackLJ,SatoM,RowleyE,MageeD,BekeleA,WilliamsD, 1994.Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats,J Clin Invest 93 63 -
OminskyMS,VlasserosF,JoletteJ,SmithSY,StouchB,DoellgastG, 2010.Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength,J Bone Miner Res 25 948 -59
FolwarcznaJ,Kaczmarczyk-SedlakI,PytlikM,NowinskaB,CegielaU,SliwinskiL, 2009.Effect of low-dose tacrolimus coadministered with raloxifene on the skeletal system in male rats,Acta Poloniae Pharmaceutica 66 207 -12
CaoZT,SwiftTA,WestCA,RosanoTG,RejR, 2004.Immunoassay of estradiol: unanticipated suppression by unconjugated estriol,Clin Chem 50 160 -5
AzingeEC,BolarinDM, 2006.Osteocalcin and bone-specific alkaline phosphatase in sickle cell haemoglobinopathies,Niger J Physiol Sci 21 21 -5
ScarianoJK,GarryPJ,MontoyaGD,ChandaniAK,WilsonJM,Baumgartner RN, .Serum leptin levels, bone mineral density, -
TschuorF,ZiniE,SchellenbergS,WengerM,BorettiFS,ReuschCE, 2012.Evaluation of four methods used to measure plasma insulin-like growth factor 1 concentrations in healthy cats and cats with diabetes mellitus or other diseases,Am J Vet Res 73 1925 -31
FindlayJW,DillardRF, 2007.Appropriate calibration curve fitting in ligand binding assays,AAPS J 9 E260 -7
BurtisCA,AshwoodER,BrunsDE, 2012.,Tietz Textbook of Clinical Chemistry and Molecular Diagnostics 1739 -51
LinC,JiangX,DaiZ,GuoX,WengT,WangJ, 2009.Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/β-catenin signaling,J Bone Miner Res 24 1651 -61
PadhiD,JangG,StouchB,FangL,PosvarE, 2011.Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody,J Bone Miner Res 26 19 -26
TasciA,BilgiliH,AltunayH,GecitM,KeskinD., 2011.Prospective evaluation of Vitamin K2, Raloxifene and their coadministration in osteoporotic rats,Eur J Pharm Sci 43 270 -7
LiC,OminskyMS,TanHL,BarreroM,NiuQT,AsuncionFJ, 2011.Increased callus mass and enhanced strength during fracture healing in mice lacking the sclerostin gene,Bone 49 1178 -85
AlaeeF,VirkMS,TangH,SugiyamaO,AdamsDJ,StolinaM, 2014.Evaluation of the effects of systemic treatment with a sclerostin neutralizing antibody on bone repair in a rat femoral defect model,J Orthop Res 32 197 -203
TianX,JeeWS,LiX,PasztyC,KeHZ, 2011.Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model,Bone 48 197 -201
SinderBP,SalemiJD,OminskyMS,CairdMS,MariniJC,KozloffKM, 2015.Rapidly growing Brtl/+ mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatment,Bone 71 115 -23
BukataSV, 2011.Systemic administration of pharmacological agents and bone repair: what can we expect,Injury 42 605 -8
TakedaS,SakaiS,ShiraishiA,KoikeN,MiharaM,EndoK., 2013.Combination treatment with eldecalcitol (ED-71) and raloxifene improves bone mechanical strength by suppressing bone turnover and increasing bone mineral density in ovariectomized rats,Bone 53 167 -73
PeanoBJ,CrabtreeJS,KommBS,WinnekerRC,HarrisHA, 2009.Effects of various selective estrogen receptor modulators with or without conjugated estrogens on mouse mammary gland,Endocrinology 150 1897 -903